Exercise programs during cancer care tied to longer survival in 21 randomized trials

Exercise has become a routine part of cancer care, mostly for what it does for daily life: less fatigue, better mood, more strength. Whether it also helps people live longer has been harder to show. Most of that evidence came from observational studies, and people who exercise differ in many ways from people who do not.

A meta-analysis in the British Journal of Sports Medicine pooled 21 randomized trials, the design that can separate exercise from those other differences. People assigned to structured exercise programs were less likely to die during the trials, and less likely to have their cancer return.

What was already known about exercise and cancer

The National Cancer Institute describes strong evidence that higher levels of physical activity are linked to lower risk of several types of cancer, including breast and colon cancer. For people who already have cancer, it cites a 2018 American College of Sports Medicine roundtable that concluded exercise training and testing are generally safe for cancer survivors.

That roundtable also found strong evidence that moderate-intensity aerobic training and/or resistance exercise during and after cancer treatment can reduce anxiety, depressive symptoms, and fatigue and improve quality of life. What remained uncertain was survival. As the new review puts it, the definitive role of exercise as a therapeutic intervention to prolong survival remains uncertain.

How the exercise and cancer survival analysis worked

The researchers searched six databases up to December 2025. They looked for randomized trials of structured exercise in adults with confirmed cancer that reported survival or tumor outcomes. They found 21 that qualified.

Structured exercise means a planned program with set amounts and intensity, usually supervised or supported, rather than general advice to move more. MedlinePlus describes the main types as aerobic exercise such as walking, running or swimming, and strength training with weights, bands or body weight. The trials used both.

What happened to survival with exercise

Across 11 trials with 3,828 people, structured exercise was associated with significant improvements in overall survival. The risk of death during follow-up was about 23% lower. Disease-free survival, meaning time without the cancer returning or a new one appearing, was also better, and both all-cause and cancer-specific deaths were lower.

Not every measure moved. There was no clear effect on progression-free survival, which tracks how long advanced cancer stays stable, or on complete tumor response to treatment before surgery. The review rated the certainty of the survival evidence as moderate, meaning further research could change the estimates.

Benefits looked larger in people who stuck with their programs, in those doing aerobic exercise and in those with early-stage disease. These were exploratory comparisons, so they point to questions rather than settled answers.

How the exercise findings fit with the CHALLENGE trial

The strongest single piece of evidence comes from the CHALLENGE (Colon Health and Life-Long Exercise Change) trial, published in 2025. It ran at 55 centers. It randomly assigned 889 people who had finished chemotherapy for colon cancer to a three-year exercise program or to health-education materials alone.

After a median of nearly eight years, the 5-year disease-free survival was 80.3% in the exercise group and 73.9% in the health-education group. That is a gap of 6.4 percentage points: roughly six more people in every hundred were free of cancer at five years. Survival also differed. The 8-year overall survival was 90.3% in the exercise group and 83.2% in the other group.

Those absolute numbers matter. A relative figure such as “23% lower risk” sounds large, but its meaning depends on how common death or recurrence is to begin with. In CHALLENGE, most people in both groups were alive and well years later. The new meta-analysis suggests that result is not a one-off, although CHALLENGE itself is a large part of the evidence.

What the cancer exercise trials cannot tell us

The trials covered different cancers, stages, treatments and programs. Pooling them blurs those differences. Survival was a secondary outcome in many of them. People who volunteer for exercise trials may also be fitter and more motivated than typical patients.

Blinding is impossible in exercise research, since people know whether they are exercising. The review cannot say which cancers benefit most, what dose of exercise is needed, or whether the same results apply to people with advanced disease.

What this adds to exercise in cancer care

The review’s authors conclude that the results support consideration of structured exercise as an effective adjuvant therapy in cancer care, with possible benefits for survival and recurrence beyond quality of life. Adjuvant means a treatment added to the main treatment, not a replacement for it.

In practice, exercise during and after cancer treatment is planned around each person’s cancer, treatment and fitness, often with specialist input. The trials tested supervised programs alongside standard care, and that is the setting their results apply to.